Bobak R. Azamian, President/CEO and Board Chair: Tarsus Pharmaceuticals TARS Sell · Filed 06/22

Trade details

Type: Insider sale
Amount: $334,886.58
Shares · price: 5,418 sh · $61.81 a share
Held after: 847,991 sh
Stock: Tarsus Pharmaceuticals TARS
Person: Bobak R. AzamianPresident/CEO and Board Chair
Trade date: 26/06/17
Filed: 26/06/22
Days to filing: 5 days

Sold 0.6% of holdings

Share of holding sold: 0.6%

Tarsus Pharmaceuticals trades, last 26 weeks

What else happened in Tarsus Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 05/18~07/17

Bobak R. Azamian's recent trades

Bobak R. AzamianPresident/CEO and Board Chair
Planned sale10b5-1 planTarsus Pharmaceuticals
Planned sale10b5-1 plan
Tarsus Pharmaceuticals
TARS
$905.6K
10,000 sh
$905.6K
Filed 09/04
Traded 09/04
Bobak R. AzamianPresident/CEO and Board Chair
Planned sale10b5-1 planTarsus Pharmaceuticals
Planned sale10b5-1 plan
Tarsus Pharmaceuticals
TARS
$800.6K
10,000 sh
$800.6K
Filed 09/02
Traded 09/02
Bobak R. AzamianPresident/CEO and Board Chair
Sell10b5-1 planTarsus Pharmaceuticals
Sell10b5-1 plan
Tarsus Pharmaceuticals
TARS
$280.6K
4,582 sh
$280.6K
Filed 06/22
Traded 06/17
Bobak R. AzamianPresident/CEO and Board Chair
Planned sale10b5-1 planTarsus Pharmaceuticals
Planned sale10b5-1 plan
Tarsus Pharmaceuticals
TARS
$615.5K
10,000 sh
$615.5K
Filed 06/17
Traded 06/17
Bobak R. AzamianPresident/CEO and Board Chair
SellTarsus Pharmaceuticals
Sell
Tarsus Pharmaceuticals
TARS
$801.6K
11,667 sh
$801.6K
Filed 03/19
Traded 03/18

Bobak R. Azamian, Chairman — sold $334.9K of Tarsus Pharmaceuticals TARS · 0.6% of holdings · 10b5-1 plan | Whalegun